微量白蛋白尿

结论检测微量白蛋白尿是预测2型糖尿病患者CHD发病率的有意义的指标。

Conclusion Microalbuminuria is a predictive indicator of CHD in type 2 diabetic patients .

ROADMAP事后分析显示奥美沙坦预防微量白蛋白尿（MAU）具有“可观的独立于BP之外的作用”。

A pos-hoc analysis of ROADMAP demonstrated a " substantial BP-independent effect " of olmesartan in preventing microalbuminuria .

2型糖尿病患者血清LDL亚组份与微量白蛋白尿的相关性

The Relationship Between LDL Subfractions and UAER in Type-2 Diabetes Patients

在2型糖尿病患者中，微量白蛋白尿阳性组年龄、病程、血压显著高于尿微量白蛋白阴性组，差异有统计学意义（P0.05）。

Age , course , blood pressure in patients with microalbuminuria was significantly higher than that without microalbuminuria ( P0.05 ) .

老年NIDDM患者微量白蛋白尿与脂质代谢的关系及临床意义

Serum Lipids and Lipoproteins in Elder NIDDM Patients with Microalbuminuria

目的：调查重庆市部分地区代谢综合征（MS）的发生率，并探讨微量白蛋白尿（MAU）与MS的相关性。

Objective : To investigate the relationship between microalbuminuria ( MAU ) and metabolic syndrome ( MS ) .

目的观察在微量白蛋白尿发生前后应用氯沙坦对糖尿病肾病（DN）的治疗作用及其机制。

Objective To estimate the therapeutical effect and mechanism of losartan on diabetic nephropathy ( DN ) before and after microalbuminuria .

目的探讨2型糖尿病患者C反应蛋白（CRP）的变化及微量白蛋白尿（MAU）与CRP的关系。

Objective To explore the serum C-reaction protein ( CRP ) level in type 2 diabetes and the relationship between CRP and microalbuminuria ( MAU ) .

结论过夜晨尿（次尿）测定ACR诊断不同性别微量白蛋白尿确实存在差异，不同性别应采用不同的诊断标准。

Conclusion There is sex difference in ACR for the diagnosis of microalbuminuria , so sex-specific criteria should be used .

在微量白蛋白尿阴性的2型糖尿病患者中，肾功能下降组的年龄、BMI、WC显著高于肾功能正常组，差异有统计学意义（P0.05）。

In the urine micro albumin negative Age group , BMI , WC in patients with renal function decline without microalbuminuria were significantly higher than those with normal renal function group ( P0.05 ) .

在肾移植受者中，超重/肥胖者胰岛素抵抗水平、代谢综合征发生率、微量白蛋白尿发生率、尿白蛋白水平均显著高于BMI正常受者。

While in recipients with obesity or overweight , the insulin-resistance level and urine albumin level , and the incidence of MS and microalbuminuria were significantly higher than recipients without obesity or overweight .

微量白蛋白尿（microalbuminuria，MAU）是反映肾小球疾病和损伤的一项非常灵敏的指标，在糖尿病及高血压肾病方面已使用多年。

Microalbuminuria is a very sensitive indicator of glomerular disease and injury , which has been used in diabetic and hypertensive nephropathy for many years .

方法：选择分别处于微量白蛋白尿期，临床蛋白尿期及伴有肾功能损害期的3例DN患者，并以性别、年龄与患者匹配的2例正常供肾组织作为对照。

Methodology : Three DN patients presented respectively with microalbuminuria , overt proteinuria or renal function damage were selected in order to clarify the relationship between the gene expression profiles and the clinical course .

方法：分析了35例正常血压，有微量白蛋白尿的NIDDM病人，分别给予卡托普利和硝苯地平治疗，用药两年半后，评价结果。

Method : Captopril or nifedipine was given to 35 normotensive NIDDM patients who had microalbuminuria . THE HALF YEAR OF 2004 The course of treatment was half a year or more .

微量白蛋白尿组在病程、FBG、HbA1c方面较尿白蛋白正常组差异有统计学意义（P0.05），其中病程差异显著（P0.01）。

The difference in the duration of diabetes , FBG , HbAlc is statistically significant ( P 0.05 ) between microalbuminuria and normal urinary albumin group , which course of a significant difference ( P 0.01 ) .

目的分析非糖尿病人群尿白蛋白与肌酐比值（ACR）的测定结果之间的性别差异，为中国制定诊断微量白蛋白尿的性别特异性标准提供参考数据。

Objective To analyze the sex specific characters of albumin / creatinine ratio ( ACR ) in non-diabetes population , and to provide reference data for determining the sex-specific criteria of microalbuminuria .

微量白蛋白尿（microalbuminuria，MAU）是心血管危险性增加及血管反应性改变的信号，不仅反映早期肾血管和肾微血管疾病，而且提示全身血管内皮功能障碍，是全身内皮功能障碍在肾脏的表现。

Micro albuminuria is a signal of increasing cardiovascular risk and changing vascular reactivity . MAU not only reflects the early stage of renal vascular diseases and glomerular disease , but also suggests systemic vascular endothelial dysfunction .

方法初诊T2DM患者86例，按尿白蛋白排泄率分为正常白蛋白尿（NAU）组和微量白蛋白尿（MAU）组。

Method 86 preliminarily diagnosed patients of type 2 diabetes were divided into 2 groups ( normal albuminuria group and microalbuminuria group ) according to urinary albumin excretion rate .

目的了解急性肺损伤（ALI）患者中微量白蛋白尿（MAU）的发生情况，探讨尿微量白蛋白（MA）对ALI患者的器官功能障碍及病死率的预测价值。

Objective To investigate the prevalence of microalbuminuria ( MAU ) in patients with acute lung injury ( ALI ) and explore the predictive value of MAU for the prognosis of patients with ALI in intensive care unit ( ICU ) .

目的对正常血压伴持续微量白蛋白尿（MAU）2型糖尿病患者进行为期6个月的前瞻性研究，以观察联合应用缬沙坦（valsartan）和苯那普利（benazepril）的肾脏保护作用。

Objective To evaluate the preventive effect of combinative use of valsartan with benazepril for the kidney , a six months ' prospective study was conducted on type two diabetes mellitus normotensives ( DM-2n ) with persistent microalbuminuria ( MAU ) .

替米沙坦可缓解胰岛素抵抗状态，抑制肾脏VEGF及其受体flt-1，flk-1的高表达，从而改善肾脏结构和功能变化、减轻肾小球肥大和微量白蛋白尿的发生。

Telmisartan can relieve the state of insulin resistance , to inhibit the high expression of VEGF and its receptor flt-1 , flk-1 in the kidney , to improve structural and fuctional changes of the kidney , and to reduce the occurrence of glomerular hypertrophy and microalbuminuria .

方法选择正常对照组20例和2型糖尿病组60例，根据UAER将糖尿病患者分为正常白蛋白尿组（22例）、微量白蛋白尿组（20例）和临床蛋白尿组（18例）。

[ Methods ] 20 normal controls and 60 patients with type 2 diabetes mellitus were investigated . According to UAER , patients were divided into normal albuminuria group ( 22 ), microalbuminuria group ( 18 ) and clinical albuminuria group ( 20 ) .

巨量白蛋白尿的患者组，其肾病进展的危险因素与微量白蛋白尿组相似，其进展的患者肾小球滤过率较低（GFRs）且诊断有心血管疾病或心力衰竭。

The macroalbuminuria group had risk factors similar to the microalbuminuria group , and had lower glomerular filtration rates ( GFRs ) and a diagnosis of cardiovascular disease or heart failure .

方法106例2型糖尿病患者依眼底血管荧光造影（FFA）及尿白蛋白排泄率（UAER）结果，将无微量白蛋白尿（UAER<20μg/min）及视网膜病变的患者定为A组；

Method 106 patients of diabetes were divided into three groups as following according to the results of fundus fluorescein angiography ( FFA ) and urinary albumin excretion rate ( UAER ):( 1 ) group A : the patients without diabetic retinopathy and UAER < 20 mg / min ;

2型糖尿病微量白蛋白尿与氧化应激的关系

Relationship between oxidative stress and microalbuminuria in type 2 diabetic patients

微量白蛋白尿与冠脉狭窄程度相关性研究

Study on the Correlation Between Microalbuminuria and Severity of Coronary Constriction

2型糖尿病患者微量白蛋白尿与胰岛素抵抗的相关性研究

The Corelation of Insulin Resistance and Microalbuminuria in Type 2 Diabetes

微量白蛋白尿是糖尿病肾病的诊断标志，也是糖尿病肾病进展的独立危险因素；

Microglobin is a marker and independently risk factor of DN .

微量白蛋白尿与糖尿病足溃疡关系临床分析

Clinical Analysis on the Relationship between Urinary Microalbumin and Diabetic Foot Ulcer

微量白蛋白尿对非糖尿病急性心肌梗死预后的意义

Prognostic Significance of microalbuminuria in non-diabetic acute myocardial infarction Patients